MedTrace Logo

MAGZEN® Effect on Recent Anxiety Reaction

NCT03602651 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2021-08-20

No results posted yet for this study

Summary

Multicentres, observational study, prospective, to evaluate the effect of MAGZEN® in the treatment of recent anxiety reaction.

Conditions

  • Anxiety Disorders

Interventions

OTHER

Hamilton-anxiety scale (HAM-A)

Evolution of anxiety disorders is evaluated by the Hamilton-anxiety scale (HAM-A)

Sponsors & Collaborators

  • Laboratoire Dielen

    lead INDUSTRY

Principal Investigators

  • Frédéric MD ROUILLON · Hôpital St Anne

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-08
Primary Completion
2021-05-03
Completion
2021-05-14

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03602651 on ClinicalTrials.gov